| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.091 | 0.09 |